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ABSTRAK
Parasentesis dalam jumlah besar dapat menyebabkan disfungsi sirkulasi akibat parasentesis. Albumin 
dikatakan dapat mencegah terjadinya disfungsi ini. Tetapi, sayangnya dari segi harga cukup mahal dan diperlukan 
alternatif lain yang dapat digunakan untuk menggantikannya. Laporan ini membandingkan albumin dengan 
koloid dalam mencegah terjadinya disfungsi sirkulasi akibat parasentesis.
Pencarian artikel dilakukan dengan menggunakan mesin pencari PubMed, Scopus, Proquest, dan Academic 
Health Complete dari EBSCO dengan kata kunci “ascites”, “albumin”, “colloid”, “dextran”, “hydroxyethyl 
starch”, “gelatin”, dan “paracentesis  induced  circulatory  dysfunction”. Artikel dibatasi pada uji klinis dengan 
randomisasi dan meta analisis dengan pertanyaan klinis “Pada pasien dengan sirosis hati yang dilakukan 
parasentesis dengan volume besar, apakah koloid sama baik dibandingkan dengan albumin untuk mencegah 
disfungsi sirkulasi akibat parasentesis?” 
Didapatkan satu meta-analisis dan empat uji klinis dengan randomisasi. Meta analisis tersebut menyatakan 
albumin sangat superior dengan odds ratio 0,34 (0,23-0,51). Tiga uji klinis menyatakan hasil yang sama dan 
satu uji klinis memperlihatkan albumin tidak lebih superior dibandingkan koloid. Dari hasil kajian pada 
semua artikel, memang koloid belum bisa dipakai untuk menggantikan albumin dalam mencegah disfungsi 
sirkulasi akibat parasentesis, tetapi koloid dapat tetap digunakan terutama pada pasien yang dilakukan dengan 
parasentesis kurang dari lima liter.
Kata kunci: parasentesis volume besar, albumin, koloid, disfungsi sirkulasi akibat parasentesis.
ABSTRACT
Large volume paracentesis may cause paracentesis induced circulatory dysfunction (PICD). Albumin is 
recommended to prevent this abnormality. Meanwhile, the price of albumin is too expensive and there should be 
another alternative that may prevent PICD. This report aimed to compare albumin to colloids in preventing PICD.
Search strategy was done using PubMed, Scopus, Proquest, dan Academic Health Complete from EBSCO with 
keywords of “ascites”,  “albumin”, “colloid”, “dextran”, “hydroxyethyl starch”, “gelatin”, and “paracentesis 
induced  circulatory  dysfunction”. Articles was limited to randomized clinical trial and meta-analysis with 
clinical question of “In hepatic cirrhotic patient undergone large volume paracentesis, whether colloids were 
similar to albumin to prevent PICD”.
We found one meta-analysis and four randomized clinical trials (RCT). A meta analysis showed that albumin 
was still superior of which odds ratio 0.34 (0.23-0.51). Three RCTs showed the same results and one RCT showed 
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albumin was not superior than colloids. We conclude that colloids could not constitute albumin to prevent PICD, 
but colloids still have a role in patient who undergone paracentesis less than five liters.
Keywords: large volume paracentesis, albumin, colloids, paracentesis induced circulatory dysfunction.
INTRODUCTION
Large-volume paracentesis (LVP) is defined 
as single paracentesis of volume more than 5 
liters/day.1,2 This procedure is indicated when 
patient has refractory ascites. This kind of 
ascites has some criteria, such as: diuretic-
resistant ascites, diuretic-intractable ascites, early 
recurrent ascites, at least one-week duration of 
diuretic treatment.3 The American Association 
for the Study of Liver Diseases4 defined more 
easily that refractory ascites is unresponsive to 
sodium-restricted diet and high-dose diuretic 
treatment (400 mg/day spironolactone and 160 
mg/day furosemide) or the ascites recurs rapidly 
after paracentesis.
LVP becomes the main treatment in refractory 
ascites, besides transjugular intrahepatic 
portosystemic shunt, liver transplantation, and 
peritoneovenous shunt5 that are still limited in 
Indonesia. LVP may cause an impairment of 
circulatory system that is called paracentesis-
induced circulatory dysfunction (PICD). 
Paracentesis directly increases cardiac output, 
reduces cardiac filling pressure, suppresses 
renin-angiotensin, and deactivates sympathetic 
nervous systems for approximately 12 hours.6 
There are big changes in circulation, including 
cardiac output inversely reduces to baseline and 
begins to activate renin angiotensin, and activates 
the sympathetic nervous system. Renal function 
is also better in the first hour and will worsen 24 
to 48 hours after paracentesis. The circulatory 
dysfunction does not happened because of the 
decrease of circulatory blood volume secondary 
from rapid accumulation of ascites, but because of 
the accentuation of arterial vasodilatation which 
will form “new” ascites.6 PICD is recognized by 
an increase of plasma renin activity of >50% of the 
pretreatment value on day 4-6 after paracentesis 
to a level >4 ng/ml hours.1
PICD may occur till six days after paracentesis 
and will activate renin-angiotensin system which 
is related to a rapid return of ascites, renal failure, 
and worsened prognosis.7 International Ascites 
Club2 and American Association for the Study 
of Liver Diseases4 recommended infusion of 
albumin 6-8 gram/liter of ascites removed when 
large volume paracentesis is performed in hepatic 
cirrhotic patient. This was based on different 
incidence of PICD treated with albumin and 
synthetic plasma expanders that only happened 
in patients whom had paracentesis more than 5 
liters.6 Moreover, PICD happens in 80% patients 
not receiving any infusion.7 Unfortunately the cost 
of albumin is too high. There are many trials that 
try to replace albumin with more cost-effective 
fluids. In this evidence-based case report, we want 
to look for new evidence to find good alternative 
(colloids) to replace albumin in large volume 
paracentesis.
CLINICAL QUESTION
A-49 year old patient with tense ascites was 
planned to undergo large volume paracentesis. She 
was hospitalized for paracentesis three months ago 
and came again due to the ascites. The physical 
examination showed normal hemodynamic 
with blood pressure 110/70 mmHg. Laboratory 
examination revealed albumin of 2.65 g/dL. In 
Indonesia national insurance, albumin transfusion 
will not be covered if albumin serum is more 
than 2.5 g/dL. Meanwhile, albumin transfusion 
is recommended when large volume paracentesis 
is performed. We would like to know whether 
colloids can replace albumin in large volume 
paracentesis in preventing paracentesis-induced 
circulatory dysfunction.
In hepatic cirrhotic patients with ascites 
that underwent large volume paracentesis, 
are colloids not inferior to albumin to prevent 
paracentesis-induced circulatory dysfunction?
METHODS
The article searching was conducted in 
PubMed, Proquest, Academic Search Complete 
(EBSCO), and Scopus in June 14th 2015 
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related to the PICO (Table 1), using search 
tools containing keywords of ascites, colloids, 
albumin, paracentesis-induced circulatory 
dysfunction with synonyms and related terms. 
(Table 2) Search strategy in each search engine 
is described in Figure 1 including the inclusion 
and exclusion criteria.
Selection
After doing the searching, five articles were 
obtained. No duplicate article in four search 
engines and all articles were available and taken 
to be appraised. There were one meta-analysis 
and four randomized clinical trials.
RESULTS
Bernardi et al8 did a meta-analysis and they 
found from 8 studies performed from 1990-
2010 that albumin has OR 0.34 (CI 95%: 0.23-
0.51), favorable than other volume expanders 
in preventing post-paracentesis circulatory 
dysfunction. They also found that hyponatremia 
can be prevented with albumin better than 
colloids (OR: 0.61; CI 95%: 0.4-0.93). It seemed 
that it may reduce mortality (OR: 0.65; CI 95%: 
0.42-1.01). Ascites recurrence, renal impairment, 
hepatic encephalopathy, portal hypertensive 
bleeding, and hospital readmission cannot be 
reduced with albumin.
Alsebaey9 did not find significant difference 
comparing terlipressin, HES 130/0.4, midodrine, 
albumin 2 grams/liter, and albumin 6 grams/liter 
in preventing incidence of PICD (8%, 8%, 20%, 
12%, 12%, respectively). HES 6% was given at 
dose of 8 grams/liter ascites removed and given 
half dose within 2 hours and the rest 6 hours 
after procedure. Albumin was administered 
at dose mentioned above with the same way 
of administration. Plasma renin activity was 
checked at baseline and 6 days after paracentesis. 
Unfortunately each group only consisted of 
25 patients. The study was done in Egypt and 
Table 1. PICO (patient intervention comparison outcome)
Problem Intervention Comparison Outcome
Hepatic cirrhotic patients with ascites that 
undergone large volume paracentesis Colloids Albumin
Paracentesis-induced circulatory 
dysfunction
Table 2. Search strategy according clinical question conducted in June 14th 2015
Search engine Terms Articles
Proquest
ascites AND paracentesis AND (colloids OR hydroxyethyl starch OR dextran OR 




(((("ascites"[MeSH Terms] OR "ascites"[All Fields]) AND ("paracentesis"[MeSH Terms] 
OR "paracentesis"[All Fields])) AND ("albumins"[MeSH Terms] OR "albumins"[All 
Fields] OR "albumin"[All Fields])) AND (paracentesis-induced[All Fields] AND 
("blood circulation"[MeSH Terms] OR ("blood"[All Fields] AND "circulation"[All 
Fields]) OR "blood circulation"[All Fields] OR "circulatory"[All Fields]) AND 
("physiopathology"[Subheading] OR "physiopathology"[All Fields] OR "dysfunction"[All 
Fields]))) AND (("colloids"[Pharmacological Action] OR "colloids"[MeSH Terms] 
OR "colloids"[All Fields] OR "colloid"[All Fields]) OR ("hydroxyethyl starch 
derivatives"[MeSH Terms] OR ("hydroxyethyl"[All Fields] AND "starch"[All Fields] 
AND "derivatives"[All Fields]) OR "hydroxyethyl starch derivatives"[All Fields] OR 
("hydroxyethyl"[All Fields] AND "starch"[All Fields]) OR "hydroxyethyl starch"[All 
Fields]) OR ("dextrans"[MeSH Terms] OR "dextrans"[All Fields] OR "dextran"[All 




ascites AND albumin AND ( colloid OR dextran OR hydroxyethyl starch OR gelatin ) 
AND paracentesis induced circulatory dysfunction 1
Scopus
ascites  AND  albumin  AND  ( colloid  OR  dextran  OR  hydroxyethyl  starch  OR  
gelatin )  AND  paracentesis  induced  circulatory  dysfunction  AND  ( LIMIT-TO 
( DOCTYPE ,  "re" )  OR  LIMIT-TO ( DOCTYPE ,  "ar" ) )  AND  ( LIMIT-TO ( 
LANGUAGE ,  "English" ) )
56
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albumin 6 grams/liter costs seven times than 
HES 130/0.4. Further analysis showed that the 
baseline of MELD score was lower in HES and 
albumin (11.76 versus 15.28), but not so different 
in CTP score (9.48 versus 9.88). It is quite hard 
to compare equally between HES and albumin 
in this study.
Abdel-Khalek10 also did a randomized 
controlled trial by comparing 68 patients with 
albumin 8 grams/liter and 67 patients with HES 
6%. The incidences of PICD were 8.8% and 
23.9%, respectively. They used albumin with 
dose 8 grams/liter and half dose was given during 
paracentesis and the other was given 6-8 hours 
after paracentesis in order to prevent volume 
overload. Meanwhile, for HES 6% the dose and 
the way in administering of the colloid was the 
same with albumin.
Garcia-Compean11 did a randomized 
controlled trial were performed in 69 patients and 
did 96 LVP of which 48 with dextran-40 and 48 
with albumin. Dextran-40 or albumin was given 
for one or two hours as soon as the LVP started. 
They found that PICD happened in 42% patients 
given dextran-40 and in 20% given albumin at 
48-hour post-paracentesis. These percentages 
were counted only from 19 patients in dextran 
group and 16 patients in albumin group because 
not all patients were checked for plasma renin 
activity.
Ginès, et al12 compared dextran 70, polygeline, 
and albumin. Albumin was given in 97 patients 
with dose of 8 grams/liter with half dose within 
the first 2 hours and the other 6-8 hours after 
paracentesis. Dextran-70 was administered to 93 
patients with the same dose and schedule with 
albumin. Next, there were 99 patients treated with 
polygeline also using the same dose and schedule 
as for albumin. Plasma renin activity was checked 
at baseline and day-6 after paracentesis. PICD in 
albumin, dextran-70, and polygeline group were 
18.5%, 34.4%, and 37.8%, respectively.
Critical Appraisal
A meta-analysis by Bernardi8 were appraised 
using meta-analysis review form, meanwhile 
there were four clinical trials that were appraised. 
Three of them, Abdel-Khalek10, Garcia-
Compean11, Ginès12, had been included in the 
meta-analysis mentioned above. Meanwhile, 
Alsebaey9 had not been included in the meta-
analysis. The appraisal forms for each type of 
study were obtained from EBM toolkit in http://
clinicalevidence.bmj.com/ and presented in 
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Figure 1. Flow chart of search strategy
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6% dextran-70, 3.5% 
gelatin, 6% HES, 10% 
dextran-40 
+ + + + + + Aggregate 0.34  (0.23-0.51) 15 34.5 0.8 5
+/- in patient means not only patient undergone large volume paracentesis.













































































+ Dextran-40 + + + 2 days - ? + + 20 42 -110 -22 5*
Gines12 
(1996) +/- Dextran-70 + + + + - ? + + 18.5 34.4 -86 -15.9 6 (3.5-29.9)
Polygeline 18.5 37.8 -104 -19.3 5 (3.2-14.6)
P:patient, +/- in P: not all patients were performed large volume paracentesis. I: intervention, HES: hydroethylstarch. 
C: comparison, +: albumin. O: outcome, +: paracentesis induced circulatory dysfunction. In validity, +: yes, -: no. CER: control 
event rate, event=outcome. EER: experimental event rate, event=outcome. RRR: relative risk reduction, minus (-):relative 
risk increase.  ARR: absolute risk reduction, minus (-):absolute risk increase. NNT: number needed to treat, if the ARR in 
minus, so it becomes number needed to harm. *95% CI of NNT can not be counted because no available data.
DISCUSSION
PICD may occur as hypotension caused 
by arteriolar vasodilatation and hypervolemic 
hyponatremia, and if severe it may lead to 
hepatorenal syndrome and death.13,14 It can also 
induce a rapid return of ascites and renal failure 
that is not easily reversible and will reduce 
survival rate.7 Increased plasma renin activity 
may reduce survival to 6 months from 57 months 
in normal plasma renin activity.15
According to several studies (Gines, et al12 
and Abdel-Khalek, et al10) found in this report, 
albumin was found to prevent PICD when given 
8 grams/liter ascites removed given half dose 
at the first 2 hours and the other 6-8 hours after 
paracentesis better than colloids (dextran 70, 
polygeline, and HES 6%). Garcia-Compean, et 
al11 also showed that dextran 40 was not better 
than albumin. The way of albumin administration 
they did was as soon as the LVP done for 1-2 
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hours. Unfortunately, they did not check renin 
activity in all patients, they only did in 36% 
of patients. Stronger evidence from the meta 
analysis with good validity by Bernardi, et al8 
also showed that including in 8 trials, albumin is 
better than other plasma expanders in preventing 
PICD (OR: 0.34), only one study showed 
albumin is no better than colloid, but the evidence 
is weak because of small sample size (n=25 in 
each group).9
The different results from each trial as 
mentioned above may be caused by different 
baseline characteristics of the patients in each 
trial. Some of baseline characteristics are 
shown in Table 5. PICD happened in patients 
receiving any colloid ranging from 8% to 42% 
and in patients receiving albumin in 8.8-20%. 
Moreover, in our opinion, the result from meta 
analysis should be interpreted carefully since the 
baseline characteristics of each trial were varied, 
particulary the amount of ascitic fluid removed 
was varied from 5.5 to 15.9 liters.8
When compared with crystalloid, albumin is 
also better in reducing PICD. Sola-Vera, et al16 
compared albumin with saline 3.5% in LVP. They 
began the infusion 3 hours after paracentesis. The 
dose of albumin and 3.5% saline were 8 gr/L 
and 170 mL/L of ascites removed, respectively.
Although there is no data concerning 
colloid versus placebo, we also suggest colloid 
infusion if albumin is not possible. Other trial 
compared paracentesis alone with paracentesis 
plus albumin (dose 10 gram/L of ascitic 
fluid removed), there was significant less 
PICD in albumin group (16%) compared with 
paracentesis alone (30%).17 Albumin may look 
superior in terms of preventing PICD, but there 
is lack of data comparing saline with colloid. 
Repeated paracentesis (<5L) may lessen the 
need for albumin, but there is also no sufficient 
data that showed significant advantage of total 
paracentesis compared with repeated smaller-
volume paracentesis.17
We should note that in patients undergoing 
smaller volume paracentesis (less than 5 liter), 
colloid infusion is needed with dose as given 
of 8 grams/liter ascites removed. From the 
original trial, Gines, et al12 compared albumin 
with colloids (dextran 70 or polygeline) infusion 
and found no significant difference in PICD 
incidence (4 of 24 patients versus 1 of 7 patients) 
for smaller volume paracentesis, hence colloid 
may be useful in patients undergone smaller 
volume paracentesis. The International Ascites 
Club also recommends the use of colloid if the 
ascitic fluid is removed less than 5 liters, although 
this is only basis on consensus.2
Further study showed as long as the ascites 
removed is less than 8 liters, and the albumin 
of 6-8 gram/liters of ascites removed is given, 
Table 5. Baseline characteristic from RCTs
Age* Child-Pugh* Serum albumin* Ascitic fluid remove* MAP*
















































(1.3) 10 (1.5) 2.9 (0.5) 3.0 (0.5) 5.7 (1.4) 5.2 (0.4) 87 (12) 89 (11)
Gines12 
(dextran) 57 (10) 59 (10)
10 
(1.4) 10 (1.3) 2.6 (0.5) 2.7 (0.5) 7.7 (2.9) 7.5 (2.5) 84 (11) 82 (11)
Gines12 
(polygeline) 57 (10) 59 (10)
10 
(1.4) 10 (1.3) 2.6 (0.5) 2.7 (0.5) 8.2 (3.6) 7.5 (2.5) 84 (13) 82 (11)
* mean (SD); RCT: randomized clinical trial; MAP: mean arterial pressure.
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the development of PICD is not associated with 
renal dysfunction.15
Besides, preventing PICD post-LVP, albumin 
also protects patient having hyponatremia 
and reduces mortality post-LVP.8 Meanwhile, 
another meta-analysis showed that albumin was 
not significantly better than other colloids in 
terms of death, encephalopathy, hyponatremia, 
gastrointestinal bleeding, readmission, renal 
impairment, and sepsis/severe infection.18
With regard to adverse effects, human 
albumin is considered to be safe. In the period 
1990 to 2000 with a total of 112 million albumin 
doses distributed worldwide, no death related 
to albumin was documented. Anaphylactoid 
reactions are very rare following albumin 
infusion and found to be higher in patients with 
ahaptoglobinemia, but much lower than gelatins 
and dextrans, similar to starches.6 Other events 
include: heart failure, increase risk of variceal 
bleeding, lung oedema, increase of nitrogen 
bodies, and viral transmission.19
Patient with refractory ascites may produce 
ascites depending on patient’s sodium intake. 
If patient with normal renal function adheres 
to sodium restriction of 88 mmol/day, the 
production of ascites should be <4 liters a week.15 
Education to restrict the consumption of sodium 
is needed in all patient with ascites in order to 
slower the production of ascitic fluid.
The main problem of using albumin is the 
cost. The price of albumin 20% per 100 mL 
in Indonesia is approximately 150 USD. To 
reduce the cost, there was a study that compared 
standard dose (8 gr/L of ascites removed) with 
half dose (4 gr/L of ascites removed) of albumin. 
The subjects were 35 patients in each group and 
they found no significant difference in incidence 
of PICD, 20% in standard dose versus 14% in 
half dose.20 Alsebaey et al9 also supported that 
incidence of PICD was not different in patients 
receiving albumin infusion of 2 gr/L of ascites 
removed with albumin 6 gr/L of ascites removed, 
altough in this study the sample size was small.
Besides LVP, evidence of albumin use 
in cirrhotic patient is also established in 
spontaneous bacterial peritonitis (SBP), 
and hepatorenal syndrome, but not enough 
in ascites, bacterial infections beside SBP, 
hypervolemic hyponatremia, and hepatic 
encephalopathy.14 Alternative treatment for 
refractory ascites is insertion of transjugular 
intrahepatic portosystemic shunt (TIPS) or liver 
transplantation as indicated.15
CONCLUSION
Up to day albumin is still superior to colloids 
and can reduce the incidence of paracentesis 
induced circulatory dysfunction in patients 
undergoing large volume paracentesis. It is 
recommended to use albumin with dose 8 grams/
liters ascites removed if it is more than five liters/
day in liver cirrhotic patients. Considering the 
high cost of albumin, half dose of albumin may 
give the same benefit although the evidence is 
weak. Colloids are still needed when paracentesis 
is done less than five liters per day.
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